Sienna Biopharmaceuticals

General Information
Business:

We are a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. Our objective is to develop our multi-asset pipeline of topical therapies that enhance the health, appearance and quality of life of dermatology patients. We are advancing multiple product candidates derived from our Topical by Design™ platform, all of which are designed to be suitable for chronic administration in patients with inflammatory skin diseases and other dermatologic and aesthetic conditions.

Industry: PHARMACEUTICAL PREPARATIONS
Employees: 40
Founded: 2010
Contact Information
Address 30699 Russell Ranch Road, Suite 140, Westlake Village, CA 91362, US
Phone Number (818) 629-2256
Web Address http://www.SiennaBio.com
View Prospectus: Sienna Biopharmaceuticals
Financial Information
Market Cap $298.2mil
Revenues $0 mil (last 12 months)
Net Income $-27.4 mil (last 12 months)
IPO Profile
Symbol SNNA
Exchange NASDAQ
Shares (millions): 4.3
Price range $14.00 - $16.00
Est. $ Volume $65.0 mil
Manager / Joint Managers J.P. Morgan/ Cowen/ BMO Capital Markets
CO-Managers -
Expected To Trade: 7/27/2017
Day: Thursday
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change